Skip to main content

Thrombosis

Volume 464: debated on Monday 15 October 2007

To ask the Secretary of State for Health what discussion the Chief Medical Officer (CMO) and his Department's Implementation Working Group have had with the National Institute for Health and Clinical Excellence (NICE) on the differences between the CMO's recommendations for the prevention of venous thromboembolism (VTE) in hospitalised patients and the NICE guidelines on reducing the risk of VTE in patients undergoing surgery; and if he will make a statement. (154349)

The Chief Medical Officer and Dr. Anita Thomas OBE, the chair of the Implementation Working Group, have had discussions with the National Institute for Health and Clinical Excellence about improving the prevention and management of venous thromboembolism (VTE). The focus of these discussions has been on how all parties can work closely together to ensure that the risk of VTE can be minimised, for example by assessing what needs to be done to make a risk assessment for every hospitalised patient a reality.